Mi
MiNT Ther
Stockholm SEFounded 201915 employees
Private CapbiotechPrivateHematology
Platform: Gene Reg
Market Cap
N/A
All Drugs
2
Clinical Trials
2
Failed / Terminated
0
FDA Approved
0
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Elranesiran | MIN-2316 | Phase 1 | 1 | RET | NSCLC | ||
| Darasertib | MIN-6117 | Phase 1/2 | 1 | AHR | Migraine |
Financial Documents
This is a private company — SEC filings are not available.
Catalyst Events (2)